Antwerp University Hospital, Department of Thoracic and Vascular Surgery, Drie Eikenstraat 655, B 2650 Edegem, Belgium.
Antwerp University Hospital, Clinical Trial Center (CTC), CRC Antwerp, Drie Eikenstraat 655, B 2650 Edegem, Belgium.
Diabetes Res Clin Pract. 2022 Jul;189:109972. doi: 10.1016/j.diabres.2022.109972. Epub 2022 Jun 26.
This study assessed temporal trends in the incidence of lower extremity amputations (LEA) in Belgium from 2009 to 2018, and subsequent secondary amputation rates.
Nationwide data on LEA were collected. Sex- and age-adjusted annual incidence rates were calculated. Time trends were analysed in negative binomial models. The incidence of secondary interventions, defined as either any ipsilateral reamputation or any contralateral amputation, was studied with death as competing risk.
41 304 amputations were performed (13 247 major, 28 057 minor). In individuals with diabetes, the amputation rate (first amputation per patient per year) decreased from 143.6/100.000 person-years to 109.7 (IRR 0.97 per year, 95 %CI 0.96-0.98, p < 0.001). The incidence of major LEAs decreased from 56.2 to 30.7 (IRR 0.93, 95 %CI 0.91-0.94, p < 0.001); the incidence of minor amputations showed a non-significant declining trend in women (54.3 to 45.0/100 000 person years, IRR 0.97 per year, 95 %CI 0.96-0.99), while this remained stable in men with diabetes (149.2 to 135.3/100 000 person years, IRR 1.00 per year, 95 %CI 0.98-1.01). In individuals without diabetes, the incidence of major amputation didn't change significantly, whereas minor amputation incidence increased (8.0 to 10.6, IRR 1.04, 95 %CI 1.03-1.05, p < 0.001). In individuals with diabetes, one-year secondary intervention rates were high (31.3% after minor, 18.4% after major LEA); the incidence of secondary amputations didn't change.
A significant decline in the incidence rate of major LEA was observed in people with diabetes. This decline was not accompanied by a significant rise in minor LEA. The incidence of secondary interventions remained stable.
本研究评估了 2009 年至 2018 年期间比利时下肢截肢(LEA)的发病率的时间趋势,以及随后的二次截肢率。
收集了全国范围内关于 LEA 的数据。计算了男女年龄调整后的年度发病率。采用负二项式模型分析时间趋势。以死亡为竞争风险,研究了继发性干预(定义为同侧再截肢或对侧截肢)的发生率。
共进行了 41304 例截肢手术(大截肢 13247 例,小截肢 28057 例)。在糖尿病患者中,截肢率(每位患者每年的首次截肢率)从 143.6/100000 人年降至 109.7(IRR 每年 0.97,95%CI 0.96-0.98,p<0.001)。大 LEAs 的发病率从 56.2 降至 30.7(IRR 0.93,95%CI 0.91-0.94,p<0.001);女性小截肢的发病率呈下降趋势(54.3 至 45.0/100000 人年,IRR 每年 0.97,95%CI 0.96-0.99),而男性糖尿病患者的发病率保持稳定(149.2 至 135.3/100000 人年,IRR 每年 1.00,95%CI 0.98-1.01)。在无糖尿病患者中,大截肢的发病率没有显著变化,而小截肢的发病率有所增加(8.0 至 10.6,IRR 1.04,95%CI 1.03-1.05,p<0.001)。在糖尿病患者中,一年后的继发性干预率较高(小截肢后为 31.3%,大 LEA 后为 18.4%);继发性截肢的发病率没有变化。
在糖尿病患者中,大 LEA 的发病率显著下降。这种下降并没有伴随着小 LEA 的显著上升。继发性干预的发生率保持稳定。